Top 3 Health Care Stocks That Are Preparing To Pump This Quarter

1. Prothena's RSI is at 21.9, indicating oversold conditions. 2. Stock price has fallen 31% recently; currently at $7.10. 3. Clinical trial data expected in 2025 could influence future performance. 4. Weaker quarterly results posted on May 8 raises investor concerns. 5. Momentum score of 5.29 shows potential for recovery despite current challenges.